Acquisitions30 March 2026 at 12:40 pm
Capfin India's Jagdish Umakant Nayak Acquires 0.42% Stake in Clinitech Laboratory Limited
AI Summary
Capfin India Ltd's Jagdish Umakant Nayak has disclosed the purchase of 9,600 equity shares of Clinitech Laboratory Limited, a company listed on the Bombay Stock Exchange. This acquisition was made on March 30, 2026, and it increases his holding to 0.42% of the total share/voting capital of the company. This disclosure was made under Regulation 29 (2) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations 2011.
Key Highlights
- Jagdish Umakant Nayak, a promoter of Capfin India Ltd, purchased 9,600 equity shares of Clinitech Laboratory Limited.
- The acquisition was made on March 30, 2026, through the open market.
- This purchase increases Mr. Nayak's holding to 0.42% of the total share/voting capital of Clinitech Laboratory Limited.
- The total share/voting capital of Clinitech Laboratory Limited after the acquisition is 22,82,400.
- The total diluted share/voting capital of Clinitech Laboratory Limited after the acquisition is also 22,82,400.
CAPFINOther Financial Services
Capfin India LtdPrice Impact